Abstract
Background
Oocysts serve as the primary source of Toxoplasma infection. Therefore, understanding oocyst development and exploring effective strategies to prevent oocyst excretion are crucial for controlling toxoplasmosis.
Methods
In this study, shotgun metagenomics was employed to characterize the functional and compositional changes in the gut microbiota of cats during oocyst development. The Spearman correlation test was utilized to analyze the correlation between differential Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways and carbohydrate-active enzymes (CAZymes) in key bacteria regulating oocyst excretion.
Results
The results revealed that group A (sexual initiation stage) displayed a lower number of functional genes, which were restored to normal levels in group B (oocyst excretion stage), compared with group C (Toxoplasma-uninfected samples). The abundance of 39 KEGG pathways, 106 CAZymes, and 98 virulence factors (VFs) varied significantly among the three groups. The atrazine degradation pathway, associated with sexual development, was upregulated in group B. CAZymes involved in restoring the intestinal mucosal barrier and VFs related to iron metabolism, antibiotic resistance, and suppression of host immunity were enriched in group B. Sexual initiation and oocyst excretion resulted in reduced gut bacterial diversity and microbiota dysbiosis. Probiotics and bacteria related to linoleic acid (LA) uptake were dominant in both group A and group B. Bacteroides stercoris was the most significantly upregulated bacterium and could influence the expression of carbohydrate-binding modules (CBMs) and glycoside hydrolases (GHs) in group B.
Conclusions
During the oocyst development/excretion stage, the function and composition of the cat gut microbiota changed significantly. In addition, Bacteroides stercoris may play a crucial role in oocyst excretion by regulating key candidates of CBMs and GHs. Our findings lay the foundation for investigating the regulatory mechanisms of oocyst excretion.
Graphical Abstract
Keywords: Toxoplasma gondii, Oocyst excretion, Cat, Gut microbiota, Function and composition
Background
Toxoplasma gondii (T. gondii), regarded as one of the most successful parasites, is capable of infecting any warm-blooded animal. It is estimated that approximately 30% of the global population is infected with T. gondii [1]. The seroprevalence of T. gondii can exceed 80% in both humans and animals in some regions, such as Egypt, Brazil, and France [2, 3]. In China, there has been an increasing trend in seroprevalence rates, with a prevalence ranging from 2.3% to 35.6% in humans and 1.3% to 82.7% in animals [4]. T. gondii infection brings serious threats to both human health and livestock production. In Brazil, the prevalence of congenital toxoplasmosis ranges from 0.4 to 2 cases per 1000 newborns [5], and approximately one fifth of infected individuals experience persistent visual impairment [6, 7]. Toxoplasma infection in Egypt has been linked to increased mortality rates among pediatric patients diagnosed with brain tumors [8]. Recent studies have also revealed a correlation between chronic Toxoplasma infection and mental disorders in humans, including schizophrenia, depression, suicidal behavior, and obsessive–compulsive disorder [9–12]. Consequently, toxoplasmosis has become an important global public health concern.
Oocysts, excreted into the environment, play an important role in the transmission of toxoplasmosis. They serve as the main source for T. gondii infection among aquatic and semi-aquatic animals [13]. All outbreaks of toxoplasmosis in Brazil have been attributed to oocysts since 2000 [14]. Although most adult infections occur via ingestion of tissue cysts from infected meat, children in Europe also become infected through oocysts. In addition, oocysts contribute to outbreaks of toxoplasmosis in pigs and an increase in the mortality rate of immunocompromised individuals in China [15].
Cats, one of the closest companions to humans, are also the most important definitive hosts of T. gondii, with a wide range of seropositivity varying from 2.2% to 100% [16]. Within 1–3 weeks of primary T. gondii infection, they can shed up to 20 million oocysts per day for 10–20 days in their feces. It is noteworthy that infected feral cats may intermittently shed oocysts throughout their lifespan [17]. Moreover, oocysts are stable for up to 18 months under unfavorable environmental conditions and resistant to many chemical disinfectants [18]. Infectious oocysts can contaminate water sources, food, and soil. Surprisingly, even a single oocyst has the potential to induce infection in animals [19].
Therefore, exploring effective strategies to prevent oocyst excretion is crucial for controlling toxoplasmosis. It is well known that T. gondii can only initiate sexual reproduction in feline intestines; thus, the feline gut microbiota may have key correlations with a successful initiation of sexual reproduction, as well as the oocyst excretion process. There are also previous studies showing that other intestinal protozoan parasites, such as Cryptosporidium and Giardia, could cause significant alterations in the host gut microbiota function and composition, thereby modulating the progression of protozoan infection and the outcome of parasitic disease [20–24]. However, up to now, few studies on the alterations of the gut microbiota of T. gondii definitive hosts have been reported.
Thus, in the present study, we hypothesized that the gut microbiota composition and functions of T. gondii’s definitive host may be significantly altered to facilitate parasite excretion during the sexual reproduction process. Therefore, we have selected the highly prevalent Chinese I TgCtwh6 strain to infect Chinese fox tabby cats, establishing an animal model for Toxoplasma oocyst excretion. Shotgun metagenomics was used to investigate variations in the gut microbial function and composition during the sexual initiation phase and the oocyst excretion phase, to explore potential key bacteria affecting oocyst development. This study has revealed the impact of Toxoplasma oocyst development on cat gut microbiota and laid a fundamental basis for investigating the regulatory mechanism of oocyst excretion.
Methods
Animals and parasite strains
Cats: Female fox tabby cats from southwest China, known for their relatively docile nature, were chosen as the experimental animals in this study. The experimental cats had been housed in our laboratory under identical conditions, provided with commercial feed and clean water, for an extended period. Second-generation cats, aged 3 months, were confirmed to be T. gondii-negative, free of feline immunodeficiency virus and other gastrointestinal pathogens. These cats were subsequently selected to serve as the infection models that could excrete Toxoplasma oocysts and were maintained on qualified commercial feed and sterile water in a specific pathogen-free (SPF) environment.
Mice: Specific pathogen-free (SPF) Kunming (KM) mice, aged 6–8 weeks, were obtained from Jinan Pengyue Laboratory Animal Breeding Co., Ltd. and were used to continuously culture and passage T. gondii cysts, providing parasites to facilitate Toxoplasma sexual reproduction in cats.
Parasite strain: TgCtwh6 strain (Chinese I) was donated by the Anhui Provincial Key Laboratory of Pathogen Biology, Anhui Medical University, and preserved at the Control Central Laboratory of Shandong Institute of Parasitic Disease.
Establishment of T. gondii sexual reproductive animal model
Establishment and identification methods of sexual/oocyst development in a cat model infected with TgCtwh6 strain have been previously described in our published literature [25]. Specifically, KM mice were orally infected with the TgCtwh6 strain (30 cysts each), and brain tissue cysts were collected 42 days postinfection. After counting, a total of 600 brain tissue cysts were administered orally to each cat. The infected cats were housed separately and fed the same diet of commercial feed and clean water to ensure they were not exposed to other pathogens during the oocyst development period. Their fecal samples were collected daily, dissolved in a 2% H2SO4 solution, and filtered through a 30-mesh filter to remove large debris. Then oocysts were examined under a microscope. Meanwhile, DNA of oocysts in fecal samples was extracted using the QIAamp Fast DNA Stool Mini Kit (Qiagen) and identified through polymerase chain reaction (PCR) targeting T. gondii-specific genes (529 base pairs (bp) repetitive sequence). The primers of PCR were as follows: forward 5-CGCTGCAGGGAGGAAGACGAAAGTTG-3 and reverse 5-CGCTGCAGACACAGTGCATCTGGATT-3.
Design of experimental groups
The sexual cycle of T. gondii was divided into two distinct stages: the sexual initiation stage (pre-sexual stage) and the oocyst excretion stage (sexual stage). These stages were treated as independent experimental groups to investigate the impact of oocyst development on the cat gut microbiota. Results of our previous study indicated that oocysts were absent in cats feces, while schizonts were observed within the cat intestinal epithelial cells (IECs), during the sexual initiation stage (3–5 days postinfection) [25]. Oocysts were subsequently observed in cats’ feces during the oocyst excretion stage (5 and 10 days postinfection) [25]. Therefore, three 3-month-old healthy cats were orally inoculated with TgCtwh6 cysts in this study. Fecal samples were collected from the three cats at three different developmental time points: 0 days postinfection (uninfected stage, designated as the control group C), 3–5 days postinfection (sexual initiation stage, designated as group A), and 5–10 days postinfection (oocyst excretion stage, designated as group B). The design of experimental groups is illustrated in Fig. 1. The collected fecal samples were used to characterize the functional genes and the species composition of the gut microbiota using shotgun metagenomics.
Fig. 1.
The design of the experimental groups
Fecal sample collection
The middle portion of fresh cat feces was aseptically collected using sterile samplers to ensure uniformity in sampling conditions between the experimental and control groups. Subsequently, the collected samples were divided into 0.5–2-g aliquots before being transferred into frozen tubes. These tubes were rapidly transferred to liquid nitrogen for 3 h and then stored at −80 ℃ in a refrigerator until use.
Illumina library preparation and sequencing
The total genomic DNA was extracted from the fecal sample (500 mg) using the PowerSoil DNA Isolation Kit (MO BIO) according to the manufacturer’s instructions. Subsequently, the concentration and purity of extracted DNA were analyzed using the Qubit dsDNA HS Assay Kit on a Qubit 3.0 fluorometer (Invitrogen), and its integrity and fragment size distribution were assessed on a 1% agarose gel electrophoresis. The AHTS Universal Plus DNA Library Prep Kit was used to construct the library, following the manufacturer’s recommendations, with index codes added for sequence annotation in each sample. Firstly, the DNA was fragmented through enzyme digestion, followed by end repair, and then sequencing adapters were ligated to the 3′ ends. The resulting ligation products were purified using Vazyme DNA Clean Magnetic Beads and sieves obtained from film screening. Amplification of purified product was carried out using PCR Primer Mix 3 and VAHTS HiFi Amplification Mix, followed by secondary purification with Vazyme DNA Clean Magnetic Beads. The library insert size was evaluated on the Qsep-400, while its concentration was determined using Qubit 3.0. Finally, sequencing of libraries took place on the Illumina NovaSeq6000 platform (San Diego, CA, USA) following a PE150 strategy along with reagents from the NovaSeq 6000 Reagent Kit.
Construction of non-redundant gene sets
The Trimmomatic (version 0.33) was used to filter raw reads to obtain high-quality sequencing data (clean reads). Subsequently, Bowtie2 software (version 2.2.4) was utilized to align these clean tags with the host genome sequence and eliminate any host contamination. The genome was subsequently assembled using the MEGAHIT software (version 1.1.2), excluding contig sequences shorter than 300 bp in length. Finally, the QUAST software (version 2.3) was used for comprehensive evaluation of the assembly results obtained. Gene-coding regions were identified using Meta GeneMark software (http://exon.gatech.edu/meta_gmhmmp.cgi, version 3.26). To construct a non-redundant gene set, MMseqs2 software (https://github.com/soedinglab/mmseqs2, version 11-e1a1) was applied with a similarity threshold of 95% and a coverage threshold of 90%.
Function annotation
The amino acid sequences of non-redundant gene sets were aligned with the KEGG database using Diamond (version 0.9.24) and annotated with gene ontology (GO) terms using Blast2GO (version 2.5). Subsequently, the non-redundant gene sets were queried against the Carbohydrate-Active Enzymes (CAZy) database using HMMER (version 3.0), the Comprehensive Antibiotic Database (CARD) using RGI (version 4.2.2), the Virulence Factors of Pathogenic Bacteria database (VFDB) setA and setB using BLASTP (version 2.2.31+) with an e-value threshold of < 1e−05.
Gut microbiota diversity analysis
Function diversity analysis
The composition and relative abundance of KEGG pathways, CAZymes, antibiotic resistance ontologies (AROs), and virulence factors (VFs) were statistically analyzed for each sample on the basis of gene function annotation results. Principal component analysis (PCA) and analysis of similarities (ANOSIM) were employed to compare the beta diversity and functional differences of the intestinal microbiota among different groups on the basis of KEGG, CAZy, CARD, and VFDB databases.
Species diversity analysis
The taxonomic composition and relative abundance of species in the samples were determined by aligning non-redundant gene sequences with those from the non-redundant protein database (Nr). Alpha diversity of the intestinal microbiota was assessed using Chao and Shannon indices. Beta diversity was analyzed by PCA and ANOSIM. Feature bacteria serving as biomarkers were identified through Linear discriminant analysis Effect Size (LEfSe).
Statistical analysis
Metagenomic sequencing data were acquired using the Illumina HiSeq PE250 system. Wilcoxon tests were utilized to evaluate variations in multiple variables among different groups. Principal coordinates analysis (using Bray–Curtis distance) was conducted using the vegan package. ANOSIM was performed utilizing the vegan R package. The correlation between KEGG pathways and CAZymes of key bacteria was examined through the Spearman correlation test. The statistical significance level was set at P < 0.05 for all analyses.
Results
Functional gene changes of the cat gut microbiota at the sexual initiation stage
Oocysts were observed in the fecal samples of group B through microscope examination, while they were absent in the other two groups (group A and group C) (Fig. 2a). Simultaneously, PCR result of Toxoplasma-specific 529 bp repeat sequence was detected in the fecal samples of group B, while it was absent in groups A and C (Fig. 2b). The gene sequence data of gut microbiota was successfully obtained using metagenomic sequencing technology from the three groups. After removing redundant sequences, a total of 319,195 non-redundant genes were acquired, with an average of 35,466 genes per group and an average gene length of 721 bp. The non-redundant gene counts for each group were depicted in Fig. 2c. Compared with group C, group A exhibited a substantial decrease in the function genes, whereas group B was restored to a level comparable to group C (Fig. 2d).
Fig. 2.
Identification of oocysts and comparative analysis of microbial gene counts in the three groups. a Microscopic examination of oocysts in fecal samples, with representative oocysts indicated by red arrows (400×). b PCR-based detection of oocysts in fecal samples. M: DNA marker DL2000. A, B, and C represent group A, group B, and group C, respectively. c The Venn diagram of non-redundant genes in the three groups. The differently sized, color-coded ovals represent individual groups; overlapping regions indicate the number of shared non-redundant genes, whereas non-overlapping regions represent the number of group-specific non-redundant genes. d Boxplot depicting the distribution of non-redundant gene counts across the three groups. The P-values derived from t-tests are labeled on the connecting lines (P-values are not displayed when P > 0.05)
KEGG pathway analysis of the cat gut microbiota during the oocyst development process
The beta diversity analysis result indicated significant differences in KEGG pathways of gut microbiota among three groups (Fig. 3a and b). A total of 39 KEGG pathways were identified as significantly distinct (Fig. 3c). Compared with group C, KEGG pathways related to starch and sucrose metabolism as well as aminoacyl-tRNA biosynthesis were upregulated in both group A and group B. Conversely, KEGG pathways associated with neural transmission inhibition (indicated by ▲ in Fig. 3c) and the degradation of antibacterial, anti-inflammatory, and antioxidant substances (indicated by ◆ in Fig. 3c) were downregulated. Moreover, group A exhibited upregulation in KEGG pathways linked to antibiotic biosynthesis, cell growth, tissue repair, and mucosal integrity. In contrast, group B showed upregulation in pathways involved in mitigating oxidative damage (indicated by ★ in Fig. 3c) and producing antibiotics targeting gram-negative bacteria. Interestingly, the atrazine degradation pathway, which has been shown to play a crucial role in regulating the development of male eukaryotic animals [26, 27], was also upregulated in group B.
Fig. 3.
Functional diversity of KEGG pathways in the gut microbiota. a PCA of KEGG pathways profiles. Each dot represents an individual sample, with color-coded dots indicating different experimental groups. The x-axis displays the first principal component, and the percentage indicates its contribution to sample differentiation. The y-axis shows the second principal component, and the percentage represents its contribution to sample differentiation. b ANOSIM of KEGG pathways. “Between” refers to the beta distance of samples between all groups, and the following sets represent beta distance within each group. An R value close to 1 indicates that inter-group differences are greater than intra-group variations. A P < 0.05 indicates statistically significant separation among groups. c Heatmap depicting the relative abundance of differentially enriched KEGG pathways. Only pathways with P < 0.05 based on parametric differential abundance testing are shown; red indicates upregulation, and blue indicates downregulation of pathways
Functional factor changes of the cat gut microbiota during the oocyst excretion
The beta diversity analysis revealed that the T. gondii oocyst development in group A and group B induced substantial alterations in the functional diversity of gut microbiota compared with the control group (group C) (Fig. 4a–c). Specifically, the most significant variation was observed in CAZymes, followed by AROs and VFs (Fig. 4a–c). ANOSIM results indicated that T. gondii sexual initiation (group A) significantly affected the function of gut microbiota (Fig. 4d–f).
Fig. 4.
Function diversity of the gut microbiota. a–c PCA results based on CAZyme families, AROs, and VFs. Each dot represents an individual sample, with color-coded dots indicating different experimental groups. The x-axis displays the first principal component, and the percentage represents its contribution to sample differentiation. The y-axis shows the second principal component, and the percentage represents its contribution to sample differentiation. d–f ANOSIM results based on CAZyme families, AROs, and VFs. “Between” refers to the beta distance of samples between all groups, and the following sets represent beta distance within each group. An R value close to 1 indicates that inter-group differences are greater than intra-group variations. A P < 0.05 indicates a statistically significant result. g Heatmap showing the relative abundance of 40 CAZyme families significantly enriched in group B. h Heatmap depicting the relative abundance of differentially abundant CARDs. i Heatmap illustrating the relative abundance of 34 VFs significantly enriched in group A and group B. In the heatmap, red denotes upregulation, and blue indicates downregulation
CAZymes
Differential analysis of function genes revealed that the sexual initiation and oocyst excretion significantly affected 106 members of CAZymes within the gut microbiota. Compared with group C, group A exhibited a reduction in several CAZyme families, including GHs, CBMs, and polysaccharide lyases (PLs). However, certain CAZyme members were notably enriched in group A, such as carbohydrate esterases 15 (CE15), AA2, GT113, CBM25, CBM26, GH140, GH59, GT13, GH72, CE8, and GH8 (Fig. 4g). Group B showed a significant enrichment of 40 CAZymes, including 12 GHs, 8 CBMs, 7 glycosyltransferases (GTs), 12 PLs, and CE5 (Fig. 4g). Previous studies demonstrated that these enzymes not only participated in remodeling the intestinal mucosal barrier but also played crucial roles in defending against pathogen invasion [28, 29].
AROs
AROs analysis revealed a decrease in the relative abundances of cephalosporins, nucleosides, anti-fatty acids, phenylpropanol, and rifamycin antibiotics, while fluoroquinolone exhibited an increase in both group A and group B. In addition, group B had a higher relative abundance of lincomycin and carbapenem (Fig. 4h).
VFs
In the meantime, a total of 98 VFs from groups A and B exhibited significant differences compared with those in group C. Specifically, group A showed a notable enrichment of 9 VFs localized on the bacterial cell membrane, functioning as transporters and receptors (nos. 1–9 in Table 1). Group B showed a significant enrichment of 25 VFs (Fig. 4i, nos. 10–34 in Table 1), which were associated with iron ion metabolism (iucC, shuU); antibiotic resistance (ptlG, exoU, mtrD); pathogen invasion and intracellular parasitism (phoP, icsA/virG, vipD, hysA); immunosuppression (exsA, btpA, spvB, among others); as well as signal transduction (bepA).
Table 1.
Functional analysis of 34 important differential VFs
| No. | Gene ID | VFs ID | VFs gene name | VFs name | Function |
|---|---|---|---|---|---|
| 1 | 000036647 | VF0236 | ompA | OmpA | Outer membrane protein A |
| 2 | 000150693 | VF0322 | cadF | CadF | Outer membrane fibronectin-binding protein |
| 3 | 000119592 | VF0095 | pchH | Pyochelin | ABC transporter ATP-binding protein |
| 4 | 000155577 | VF0043 | bsc3 | Capsule | Polysaccharide biosynthesis protein Bsc3 |
| 5 | 000156563 | VF0467 | bauE | Acinetobactin | Ferric siderophore ABC transporter, ATP-binding protein BauE |
| 6 | 000161245 | VF0230 | iroN | IroN | Salmochelin receptor IroN |
| 7 | 000162914 | VF0225 | hlyB | Hemolysin | Hemolysin B |
| 8 | 000164438 | VF0361 | cpsG | Capsule | MurB family protein |
| 9 | 000175843 | VF0414 | ricA | RicA | Rab2 interacting conserved protein A |
| 10 | 000185057 | VF0141 | capA | Capsule | CapA, required for poly-gamma-glutamate transport |
| 11 | 000191443 | VF0566 | fimF | Type I fimbriae | Type 1 fimbrial minor component |
| 12 | 000192293 | VF0451 | mtrD | MtrCDE | Multiple transferable resistance system protein |
| 13 | 000219954 | VF0098 | exoU | ExoU | Type III secretion system effector ExoU, phospholipase A2 activity |
| 14 | 000258325 | VF0369 | bepA | VirB/VirD4 type IV secretion system | Bartonella effector protein BepA |
| 15 | 000262505 | VF0014 | N-deacetylase | Intercellular adhesion proteins | Synthesis |
| 16 | 000314238 | VF0289 | mgtC | MgtC | Possible Mg2 + transport P-type ATPase C MgtC |
| 17 | 000011155 | VF0026 | ptlG | Ptx | Ptl type IV secretion system VirB10 homolog protein PtlA |
| 18 | 000043023 | VF0084 | xcpR | XCP | General secretion pathway protein E |
| 19 | 000059275 | VF0479 | exsA | T3SS | Type III secretion system transcriptional regulator |
| 20 | 000059946 | VF0286 | phoP | PhoP | Possible two-component system response transcriptional positive regulator PhoP |
| 21 | 000078899 | VF0229 | iucC | Aerobactin | Aerobactin siderophore biosynthesis protein IucC |
| 22 | 000242704 | VF0409 | vtrA | T3SS2 | Type III secretion system transcriptional regulator |
| 23 | 000247743 | VF0344 | cdsN | TTSS | Type III secretion system ATPase |
| 24 | 000252296 | VF0256 | shuU | Shu | Permease of iron compound ABC transport system |
| 25 | 000112991 | VF0508 | yapK | YapK | Autotransporter protein YapK |
| 26 | 000122614 | VF0121 | icsA/virG | IcsA (VirG) | Autotransporter, actin tail assembly protein IcsA/VirG |
| 27 | 000123254 | VF0410 | llsG | LLS | ABC transporter ATP-binding protein LlsG |
| 28 | 000093371 | VF0308 | mbtM | FadD33 | Probable fatty acyl-AMP ligase MbtM |
| 29 | 000116805 | VF0412 | btpA | BtpA/Btp1/TcpB | Tir domain containing protein BtpA |
| 30 | 000305479 | VF0539 | ecbA | EcbA | Collagen binding MSCRAMM, EcbA |
| 31 | 000308785 | VF0156 | vipD | Dot/Icm | Dot/Icm type IV secretion system effector VipD, Phospholipase A1 |
| 32 | 000151104 | VF0013 | hysA | Hyaluronate lyase | Hyaluronate lyase precursor |
| 33 | 000182267 | VF0521 | eccA3 | ESX-3 | Type VII secretion system protein EccA3 |
| 34 | 000077725 | VF0107 | spvB | Spv | Type III secretion system effector SpvB, ADP-ribosylation activity |
Key bacterial taxa analysis of the cat gut microbiota during the sexual reproduction stage
The diversity of bacterial composition analysis
The non-redundant gene sequences were compared using National Center for Biotechnology Information (NCBI)-BLAST, revealing that the cat gut microbiota comprised five kingdoms, 64 phyla, 89 classes, 314 families, 1045 genera, and 4454 species. The alpha diversity of gut microbiota was significantly reduced in both group A and group B compared with group C, and group A exhibited a more pronounced reduction (Fig. 5a, b). Furthermore, group A demonstrated a significant alteration in the beta diversity of gut microbiota (Fig. 5c, d).
Fig. 5.
The diversity and composition of the gut microbial community. a, b Alpha diversity metrics of the gut microbiota across experimental groups. c PCA of the gut microbiota in each group. Each dot represents an individual sample; color-coded dots indicate samples from different groups. The x-axis displays the first principal component, and the percentage represents its contribution to sample differentiation. The y-axis shows the second principal component, and the percentage represents its contribution to sample differentiation. d ANOSIM assessing the gut microbiota composition across groups. “Between” refers to the beta-diversity distance calculated across all groups. An R value close to 1 indicates that inter-group differences are greater than intra-group variations. A P < 0.05 indicates statistically significant differences among groups. e, f Bar chart illustrating the taxonomic composition at both the phylum and family levels. Each species is represented by a distinct color, with the length of the corresponding color block indicating its relative abundance. g Heatmap depicting the relative abundance of 44 gut bacterial taxa enriched in group B. Red indicates upregulation of the associated pathway, while blue reflects downregulation
The dominant species of the gut microbiota were found to be Bacteroidetes, Firmicutes, Proteobacteria, and Actinobacteria. However, significant variations in their relative abundances were observed across the three groups (Fig. 5e). The composition of dominant bacteria in group A and group B showed significant differences at the family level compared with that of group C (Fig. 5f). Prevotellaceae, Lactobacillaceae, Bifidobacteriaceae, and Succinivibrionaceae were the dominant bacteria in group A, whereas Bacteroidaceae, Lachnospiraceae, Selenomonadaceae, and Lactobacillaceae were prevalent in group B (Fig. 5f).
Species-level changes in bacterial composition
The relative abundance of 289 species exhibited significant alterations in group A and group B compared with group C. Among the top 100 differential bacterial species, 44 exhibited increased abundance in group B, whereas their abundance was reduced in group A. These bacteria consisted of 16 members from Bacteroidetes, 10 members from Firmicutes, 5 members each from Proteobacteria and Actinobacteria, and 4 members from Fusobacteria (Fig. 5g). This finding suggested that Bacteroidetes and Firmicutes played crucial roles in oocyst development and excretion.
Distinctive gut bacteria at the oocyst excretion stage
LEfSe was used to analyze bacteria that exhibited significant differences in group A and group B compared with the control group (group C). The results showed that Veillonellaceae from Firmicutes exhibited significant variation in group A, while Bacteroides within Bacteroidaceae likely played a crucial role in group B. Bacteroides stercoris displayed the most pronounced changes in group B, highlighting its importance during the Toxoplasma oocyst excretion stage and potentially serving as key bacteria during this stage (Fig. 6).
Fig. 6.
The LEfSe analysis of the gut bacterial communities among the three groups of cats. The circles radiating from the inside outward represent taxonomic levels ranging from phylum to species. At each classification level, each small circle represents a distinct category, with its size proportional to the relative abundance. Different colors correspond to different taxonomic groups
Potential functional analysis of Bacteroides stercoris during the oocyst excretion stage
During the oocyst excretion stage (in group B), Bacteroides stercoris demonstrated significant enrichment in seven KEGG pathways and 14 CAZymes compared with group C and group A. The Spearman correlation test was calculated on the basis of the differences in abundance, with selection criteria set at |r|> 0.7 and P < 0.05. The findings revealed significant associations both in KEGG pathways and CAZymes (Table 2). Notably, CBM6 was significantly associated with all five signaling pathways; meanwhile, CBM4, GH11, GH51, GH97, and GH115 exhibited significant associations with four of those pathways. Consequently, Bacteroides stercoris may play key roles in the Toxoplasma oocyst excretion by influencing the expression of CBM6, CBM4, GH11, GH51, GH97, and GH115 to regulate critical related pathways, including polyketide sugar unit biosynthesis, riboflavin metabolism, and lysine degradation. These findings may provide promising targets for developing strategies to block oocyst excretion, although further studies are needed to clarify the regulatory mechanisms.
Table 2.
Correlation analysis between KEGG pathways and CAZymes in Bacteroides stercoris
| KEGG pathways | Correlated CAZymes |
|---|---|
| Pantothenate and CoA biosynthesis | CBM6, CBM48, GH115 |
| Polyketide sugar unit biosynthesis | CBM4, CBM6, GH26, GH43, GH51, GH97, GH115 |
| Riboflavin metabolism | CBM4, CBM6, GH26, GH43, GH51, GH67, GH97, GH115 |
| Lysine degradation | CBM4, CBM6, GH26, GH43, GH51, GH67, GH97, GH115 |
| Phosphonate and phosphinate metabolism | CBM4, CBM6, GH19, GH51, GH97 |
Discussion
T. gondii is recognized as the most widely distributed protozoan parasite globally. The oocysts of T. gondii play a crucial role in enhancing its transmissibility [30, 31]. Since the feline intestine is the sole site for the development and excretion of Toxoplasma oocysts, the research on functional and compositional changes in the feline gut microbiota during the sexual initiation and oocyst excretion stages of T. gondii has become urgent and relevant. The present study employed shotgun metagenomics to analyze the compositional and functional alterations in feline gut microbiota during the development and excretion stages of T. gondii oocyst, identifying a key bacterial species, Bacteroides stercoris, and relative functional factors. These findings provide mechanistic insights into the tripartite interaction among T. gondii, gut microbiome, and definitive host and may lay a foundation for future research into mechanisms and potential interventions.
Our results showed that T. gondii sexual initiation caused a significant downregulation of a large number of CAZymes genes spanning GHs, CBMs, and PLs—key mediators of mucosal barrier maintenance and immune evasion [32–35]—suggesting that the sexual initiation of tachyzoites may make the intestinal mucosal barrier more vulnerable and help parasites quickly invade intestinal epithelial cells. Intriguingly, the oocyst excretion phase exhibited a counteractive microbial adaptation, marked by the upregulation of approximately 40 CAZymes members predominantly involved in mucin glycan processing. Meantime, we also discovered that many VFs were significantly enriched at this stage. Particularly, among them, iucC and shuU are related to iron metabolism. Iron metabolism in the gut reduced host damage caused by redox reactions through bacterial siderophore-mediated iron sequestration and promoted probiotic bacteria abundance [36–38]. These variations suggest that the altered functional factors, such as CAZymes and VFs, may contribute to restoring the intestinal mucosal barrier and mitigating the gut damage induced by T. gondii.. In addition, the enrichment of antibiotic resistance genes (ARGs) against lincomycin and carbapenem at this stage can inhibit intestinal anaerobic bacteria [39, 40] and thereby potentially promote the excretion of oocysts. Similarly, this phenomenon has also been observed in mice infected with Cryptosporidium. After treating the infected mice with penicillin, the number of anaerobic bacteria in their intestines decreased. At the same time, the excretion of Cryptosporidium oocysts increased significantly [41].
Notably, the analysis of stage-specific key bacterial taxa revealed divergent microbial characteristics between the definitive and intermediate hosts. During the sexual initiation stage and oocyst excretion stage, cats exhibited significant increases in the relative abundance of Firmicutes and probiotic taxa, accompanied by a marked reduction in Proteobacteria abundance. This contrasts sharply with observations in T. gondii-infected mouse models (intermediate hosts) [42, 43], where these bacterial groups displayed opposite abundance patterns. Furthermore, when mice were infected with non-Toxoplasma parasites such as Giardia and Cryptosporidium [44, 45], the abundance variations of Firmicutes and Proteobacteria in their gut microbiota converged with those observed in T. gondii-infected mice. Collectively, these findings suggest that T. gondii exerts a unique stage-specific regulatory effect on the gut microbiota of the definitive host.
We further observed that the gut microbiota composition exhibited significant dynamic shifts across different developmental stages of T. gondii. During the sexual initiation stage, dominant bacterial families, including Prevotellaceae, Lactobacillaceae, Bifidobacteraceae, and Succinivibrionaceae may establish an immune-tolerant microenvironment for parasite sexual development via their anti-inflammatory properties and maintenance of intestinal mucosal barrier integrity [46–48]. When transitioning to the oocyst excretion stage, the microbiome underwent substantial structural remodeling, with the Bacteroidaceae, Lachnospiraceae, and Selenomonadaceae emerging as the new dominant taxa. Published studies indicate that these taxa possess multifaceted metabolic regulatory capacities such as (i) enhancing intestinal immune responses by promoting the biosynthesis of short-chain fatty acids (SCFAs), such as butyrate [50], and (ii) facilitating intestinal epithelial absorption and metabolism of linoleic acid (LA) [51]. Given that LA has been identified as a critical inducer of T. gondii sexual initiation [52], our findings collectively suggest that these dominant bacterial taxa may regulate oocyst excretion by modulating gut metabolites and reducing intestinal system damage. However, further metabolomic investigations are required to validate these mechanistic hypotheses.
Our results showed that Bacteroides stercoris may serve as a key mediator of T. gondii oocyst excretion, with its regulatory role potentially linked to the functional upregulation of CBMs and GHs. As a probiotic, Bacteroides stercoris exhibits multiple metabolic activities. It can not only promote the biosynthesis of SCFA [53] but also secrete heparinase and chondroitinase, which can degrade host-derived glycosaminoglycans [54, 55]. These observations suggest that Bacteroides stercoris may modulate oocyst excretion dynamics through dual mechanisms: (i) remodeling the intestinal metabolic milieu via SCFA-driven immunometabolic reprogramming and (ii) disrupting parasite–host interfacial structures through enzymatic degradation of critical adhesion molecules. However, its precise function requires further confirmation through in vitro co-culture studies, metabolite detection, and enzyme activity analysis. Only after these confirmations can we scientifically assess its potential as an additive in cat food to prevent toxoplasmosis in both pet and stray cats.
Although the present study has achieved enlightening results, with the use of shotgun metagenomics, coupled with the functional annotations (KEGG, CAZy, CARD, and VFDB), ensuring a comprehensive analysis of microbial functional and compositional changes, there are still inevitable limitations. First, the restricted sample size (n = 3 per group) may limit the statistical power and generalizability. Given this, we have established strict environmental controls, including standardized diets and SPF housing, to minimize confounding variables. In the following study, we will enlarge the sample size to enhance the statistical power. The integrated multi-omics strategy combining transcriptomics and targeted metabolomics simultaneously links gene function annotation with metabolic output, further exploring the dynamic interactions between the definitive host, the gut microbiota, and T. gondii.
Conclusions
Overall, our results indicate that T. gondii manipulates the cat gut microbiota through a unique mechanism to regulate oocyst development. It may manipulate the cat gut microbiota to repair the intestinal mucosa barrier and reduce damage to the intestinal system, thereby protecting intestinal epithelial cells to promote oocyst excretion. Bacteroides stercoris may serve as a principal bacterium and play a crucial role in oocyst excretion by regulating key candidates of CBMs and GHs, making it a promising candidate for investigating a regulatory strategy for controlling oocyst excretion; however, the mechanisms still need further verification in larger sample sizes.
Acknowledgements
We are very grateful to Dr. Jilong Shen (Anhui Medical University, Hefei, Anhui, China) for the provision of Chinese I T.gondii strain TgCtwh6.
Abbreviations
- KEGG
Kyoto Encyclopedia of Genes and Genomes
- CAZymes
Carbohydrate-active enzymes
- VFs
Virulence factors
- LA
Linoleic acid
- T. gondii
Toxoplasma gondii
- TgCtwh6
Wh6, a Chinese I × II hybrid genotype strain of T. gondii, isolated from a stray cat in Wuhan, China
- SPF
Specific pathogen-free
- KM
Kunming
- IECs
Intestinal epithelial cells
- GO
Gene ontology
- CAZy database
Carbohydrate-Active Enzymes database
- CARD Database
Comprehensive antibiotic database
- VFDB
Virulence factors of pathogenic bacteria
- AROs
Antibiotic resistance ontologies
- Nr
Non-redundant protein database
- PCA
Principal coordinates analysis
- ANOSIM
Analysis of similarities
- LEfSe
Linear discriminant analysis Effect Size
- GHs
Glycoside hydrolases
- CBMs
Carbohydrate-binding modules
- PLs
Polysaccharide lyases
- GTs
Glycosyltransferases
- SCFA
Short-chain fatty acids
Author contributions
G.H.Z. wrote the main manuscript text. K.Y., H.J.D., and C.X. edited the manuscript. B.B.Z., Z.H.C., T.X., and Y.N.L. completed the experimental section (methodology). H.S., H.H.X., and X.M.X. conducted the data analysis. X.Z. and X.J.J. performed the Spearman correlation test. B.B.Z., Z.H.C., Y.N.L., and W.J.Z. prepared figures. All authors read and approved the final version of the manuscript.
Funding
This work was supported by the Health Science and Technology Development Program of Shandong Province (no. 202401050157 to Z.G.; no. 202401050156 to B.Z.; and no. 202201050466 to S.H.), the Natural Science Foundation of Shandong Province (no. ZR2022MH197 to Y.K. and no. ZR2023QH253 to D.H.), the Taishan Scholars Project of Shandong Province (no. tsqn202103186 to Y.K.), Joint Innovation Team for Clinical & Basic Research (no. 202407), and the Innovation Project of Shandong Academy of Medical Sciences.
Availability of data and materials
The raw metagenomic data on cat gut microbiota of this article can be found online at: https://www.ncbi.nlm.nih.gov/sra/PRJNA1206810.
Declarations
Ethical approval and consent to participate
All animal care and experimental procedures were approved by the Institutional Animal Protection and Use Committee of Shandong First Medical University (approval no. W202103030088) and followed the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines. Cats infected with T. gondii received appropriate care, and experiments were designed to minimize animal suffering and reduce cat usage. Mice were euthanized using ether inhalation as per ARRIVE guidelines 2.0.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Gui-Hua Zhao and Bei-Bei Zhou have contributed equally to this work.
Contributor Information
Hong-Jie Dong, Email: donghongjie@sdfmu.edu.cn.
Chao Xu, Email: xu19850927@163.com.
Kun Yin, Email: kyin@sdfmu.edu.cn.
References
- 1.Molan A, Nosaka K, Hunter M, Wang W. Global status of Toxoplasma gondii infection: systematic review and prevalence snapshots. Trop Biomed. 2019;36:898–925. [PubMed] [Google Scholar]
- 2.Pinto-Ferreira F, Caldart ET, Pasquali AKS, Mitsuka-Breganó R, Freire RL, Navarro IT. Patterns of transmission and sources of infection in out-breaks of human toxoplasmosis. Emerg Infect Dis. 2019;25:2177–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Dubey JP. Outbreaks of clinical toxoplasmosis in humans: five decades of personal experience, perspectives and lessons learned. Parasit Vectors. 2021;14:263. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Pan M, Lyu C, Zhao J, Shen B. Sixty years (1957–2017) of research on toxoplasmosis in China-An overview. Front Microbiol. 2017;8:1825. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Hampton MM. Congenital toxoplasmosis: a review. Neona Netw. 2015;34:274–8. [DOI] [PubMed] [Google Scholar]
- 6.Johnson SK, Johnson PTJ. Toxoplasmosis: recent advances in understanding the link between infection and host behavior. Annu Rev Anim Biosci. 2021;9:249–64. [DOI] [PubMed] [Google Scholar]
- 7.Balbino LS, Bernardes JC, Ladeia WA, Martins FDC, Nino BSL, Mitsuka-Breganó R, et al. Epidemiological study of toxoplasmosis outbreaks in Brazil. Transbound Emerg Dis. 2022;69:2021–8. [DOI] [PubMed] [Google Scholar]
- 8.Hamouda MM, El-Saied AS, Zaher A, Khalil AF, ElBlihy AA, Nabih N, et al. Toxoplasma gondii: seroprevalence and association with childhood brain tumors in Egypt. Acta Trop. 2024;251:107123. [DOI] [PubMed] [Google Scholar]
- 9.Khademvatan S, Saki J, Khajeddin N, Izadi-Mazidi M, Beladi R, Shafiee B, et al. Toxoplasma gondii exposure and the risk of schizophrenia. Jundishapur J Microbiol. 2014;7:e12776. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Groër MW, Yolken RH, Xiao JC, Beckstead JW, Fuchs D, Mohapatra SS, et al. Prenatal depression and anxiety in Toxoplasma gondii-positive women. Am J Obstet Gynecol. 2011;204:433.e1-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Pedersen MG, Mortensen PB, Norgaard-Pedersen B, Postolache TT. Toxoplasma gondii infection and self-directed violence in mothers. Arch Gen Psychiatry. 2012;69:1123–30. [DOI] [PubMed] [Google Scholar]
- 12.Miman O, Mutlu EA, Ozcan O, Atambay M, Karlidag R, Unal S. Is there any role of Toxoplasma gondii in the etiology of obsessive–compulsive disorder? Psychiatry Res. 2010;177:263–5. [DOI] [PubMed] [Google Scholar]
- 13.Ahlers AA, Mitchell MA, Dubey JP. Risk factors for Toxoplasma gondii exposure in semiaquatic mammals in a freshwater ecosystem. J Wildl Dis. 2015;51:488–92. [DOI] [PubMed] [Google Scholar]
- 14.Zhu S, VanWormer E, Martínez-López B, Bahia-Oliveira LMG, DaMatta RA, Rodrigues PS, et al. Quantitative risk assessment of oocyst versus bradyzoite foodborne transmission of Toxoplasma gondii in Brazil. Pathogens. 2023;12:870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Liu XY, Wang ZD, El-Ashram S, Liu Q. Toxoplasma gondii oocyst-driven infection in pigs, chickens and humans in northeastern China. BMC Vet Res. 2019;15:366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Dubey JP, Cerqueira-Cézar CK, Murata FHA, Kwok OCH, Yang YR, Su C. All about toxoplasmosis in cats: the last decade. Vet Parasitol. 2020;283:109145. [DOI] [PubMed] [Google Scholar]
- 17.Dubey JP. Toxoplasmosis of animals and humans. 3rd ed. Boca Raton: CRC Press; 2021. p. 135–50. [Google Scholar]
- 18.Frenkel JK, Ruiz A, Chinchilla M. Soil survival of Toxoplasma oocysts in Kansas and Costa Rica. Am J Trop Med Hyg. 1975;24:439–43. [DOI] [PubMed] [Google Scholar]
- 19.Dubey JP, Lunney JK, Shen SK, Kwok OC, Ashford DA, Thulliez P. Infectivity of low numbers of Toxoplasma gondii oocysts to pigs. J Parasitol. 1996;82:438–43. [PubMed] [Google Scholar]
- 20.Barash NR, Maloney JG, Singer SM, Dawson SC. Giardia alters commensal microbial diversity throughout the murine gut. Infect Immun. 2017;85:e00948-e1016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Dong H, Chen X, Zhao X, Zhao C, Mehmood K, Kulyar MF, et al. Intestine microbiota and SCFAs response in naturally Cryptosporidium-infected plateau yaks. Front Cell Infect Microbiol. 2023;13:1105126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Prabakaran M, Weible LJ, Champlain JD, Jiang RY, Biondi K, Weil AA, et al. The gut-wrenching effects of cryptosporidiosis and giardiasis in children. Microorganisms. 2023;11:2323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Partida-Rodríguez O, Serrano-Vázquez A, Nieves-Ramírez ME, Moran P, Rojas L, Portillo T, et al. Human intestinal microbiota: interaction between parasites and the host immune response. Arch Med Res. 2017;48:690–700. [DOI] [PubMed] [Google Scholar]
- 24.Fujishiro MA, Lidbury JA, Pilla R, Steiner JM, Lappin MR, Suchodolski JS. Evaluation of the effects of anthelmintic administration on the fecal microbiome of healthy dogs with and without subclinical Giardia spp. and Cryptosporidium canis infections. PLoS ONE. 2020;15:e0228145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Zhao G, Zhang L, Dai L, Xu H, Xu C, Xiao T, et al. Development of Toxoplasma gondii Chinese I genotype Wh6 strain in cat intestinal epithelial cells. Korean J Parasitol. 2022;60:241–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Hayes TB, Stuart AA, Mendoza M, Collins A, Noriega N, Vonk A, et al. Characterization of atrazine-induced gonadal malformations in African clawed frogs (Xenopus laevis) and comparisons with effects of an androgen antagonist (cyproterone acetate) and exogenous estrogen (17beta-estradiol): support for the demasculinization/feminization hypothesis. Environ Health Perspect. 2006;114:134–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Carriquiriborde P, Fernandino JI, López CG, Benito ES, Gutierrez-Villagomez JM, Cristos D, et al. Atrazine alters early sexual development of the South American silverside, Odontesthes bonariensis. Aquat Toxicol. 2023;254:106366. [DOI] [PubMed] [Google Scholar]
- 28.Labourel A, Parrou JL, Deraison C, Mercier-Bonin M, Lajus S, Potocki-Veronese G. O-Mucin-degrading carbohydrate-active enzymes and their possible implication in inflammatory bowel diseases. Essays Biochem. 2023;67:331–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Hobbs EEM, Gloster TM, Pritchard L. cazy_webscraper: local compilation and interrogation of comprehensive CAZyme datasets. Microb Genom. 2023;9:mgen001086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Álvarez García G, Davidson R, Jokelainen P, Klevar S, Spano F, Seeber F. Identification of oocyst-driven Toxoplasma gondii infections in humans and animals through stage-specific serology-current status and future perspectives. Microorganisms. 2021;9:2346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Zhu S, Shapiro K, VanWormer E. Dynamics and epidemiology of Toxoplasma gondii oocyst shedding in domestic and wild felids. Transbound Emerg Dis. 2022;69:2412–23. [DOI] [PubMed] [Google Scholar]
- 32.Wardman JF, Bains RK, Rahfeld P, Withers SG. Carbohydrate-active enzymes (CAZymes) in the gut microbiome. Rev Microbiol. 2022;20:542–56. [DOI] [PubMed] [Google Scholar]
- 33.Crouch LI, Liberato MV, Urbanowicz PA, Baslé A, Lamb CA, Stewart CJ, et al. Prominent members of the human gut microbiota express endo-acting O-glycanases to initiate mucin breakdown. Nat Commun. 2020;11:4017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Hughes GW, Ridley C, Collins R, Roseman A, Ford R, Thornto DJ. The MUC5B mucin polymer is dominated by repeating structural motifs and its topology is regulated by calcium and pH. Sci Rep. 2019;9:17350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Varki A. Biological roles of glycans. Glycobiology. 2017;27:3–49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Mayneris-Perxachs J, Moreno-Navarrete JM, Fernández-Real JM. The role of iron in host-microbiota crosstalk and its effects on systemic glucose metabolism. Nat Rev Endocrinol. 2022;18:683–98. [DOI] [PubMed] [Google Scholar]
- 37.Knight LC, Wang M, Donovan SM, Dilger RN. Early-life iron deficiency and subsequent repletion alters development of the colonic microbiota in the pig. Front Nutr. 2019;6:120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Karamantziani T, Pouliakis A, Xanthos T, Ekmektzoglou K, Paliatsiou S, Sokou R, et al. The effect of oral iron supplementation/fortification on the gut microbiota in infancy: a systematic review and meta-analysis. Children (Basel). 2024;11:231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.McOrist S, Muller Wager A, Kratzer D, Sjösten CG. Therapeutic efficacy of water-soluble lincomycin-spectinomycin powder against porcine proliferation enteropathy in a European field study. Vet Rec. 2000;146:61–5. [DOI] [PubMed] [Google Scholar]
- 40.El-Gamal MI, Brahim I, Hisham N, Aladdin R, Mohammed H, Bahaaeldin A. Recent updates of carbapenem antibiotics. Eur J Med Chem. 2017;131:185–95. [DOI] [PubMed] [Google Scholar]
- 41.Charania R, Wade BE, McNair NN, Mead JR. Changes in the microbiome of Cryptosporidium-infected mice correlate to differences in susceptibility and infection levels. Microorganisms. 2020;8:879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Meng JX, Wei XY, Guo H, Chen Y, Wang W, Geng HL, et al. Metagenomic insights into the composition and function of the gut microbiota of mice infected with Toxoplasma gondii. Front Immunol. 2023;14:1156397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Shao DY, Bai X, Tong MW, Zhang YY, Liu XL, Zhou YH, et al. Changes to the gut microbiota in mice induced by infection with Toxoplasma gondii. Acta Trop. 2020;203:105301. [DOI] [PubMed] [Google Scholar]
- 44.Riba A, Hassani K, Walker A, van Best N, von Zezschwitz D, Anslinger T, et al. Disturbed gut microbiota and bile homeostasis in Giardia-infected mice contributes to metabolic dysregulation and growth impairment. Sci Transl Med. 2020;12:eaay7019. [DOI] [PubMed] [Google Scholar]
- 45.Mammeri M, Chevillot A, Thomas M, Julien C, Auclair E, Pollet T, et al. Cryptosporidium parvum-infected neonatal mice show gut microbiota remodelling using high-throughput sequencing analysis: preliminary results. Acta Parasitol. 2019;64:268–75. [DOI] [PubMed] [Google Scholar]
- 46.Chen Y, Liu Y, Wang Y, Chen X, Wang C, Chen X, et al. Prevotellaceae produces butyrate to alleviate PD-1/PD-L1 inhibitor-related cardiotoxicity via PPARalpha-CYP4X1 axis in colonic macrophages. J Exp Clin Cancer Res. 2022;41:1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Zawistowska-Rojek A, Kośmider A, Stępień K, Tyski S. Adhesion and aggregation properties of Lactobacillaceae strains as protection ways against enteropathogenic bacteria. Arch Microbiol. 2022;204:285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.van Baarlen P, Troost FJ, van Hemert S, van der Meer C, de Vos WM, de Groot PJ, et al. Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc Natl Acad Sci USA. 2009;106:2371–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Cheng J, Hu J, Geng F, Nie S. Bacteroides utilization for dietary polysaccharides and their beneficial effects on gut health. Food Sci Human Wellness. 2022;11:1101–10. [Google Scholar]
- 50.Hu S, Wang J, Xu Y, Yang H, Wang J, Xue C, et al. Anti-inflammation effects of fucosylated chondroitin sulphate from Acaudina molpadioides by altering gut microbiota in obese mice. Food Funct. 2019;10:1736–46. [DOI] [PubMed] [Google Scholar]
- 51.Salsinha AS, Pimentel LL, Fontes AL, Gomes AM, Rodríguez-Alcalá LM. Microbial production of conjugated linoleic acid and conjugated linolenic acid relies on a multienzymatic system. Microbiol Microbiol Mol Biol Rev. 2018;82:e00019-e118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Martorelli Di Genova B, Wilson SK, Dubey JP, Knoll LJ. Intestinal delta-6-desaturase activity determines host range for Toxoplasma sexual reproduction. PLoS Biol. 2019;17:e3000364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Yang Y, Zheng X, Wang Y, Tan X, Zou H, Feng S, et al. Human fecal microbiota transplantation reduces the susceptibility to dextran sulfate sodium-induced germ-free mouse colitis. Front Immunol. 2022;13:836542. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Hyun YJ, Jung IH, Kim DH. Expression of heparinase I of Bacteroides stercoris HJ-15 and its degradation tendency toward heparin-like glycosaminoglycans. Carbohydr Res. 2012;359:37–43. [DOI] [PubMed] [Google Scholar]
- 55.Wang Y, Ma M, Dai W, Shang Q, Yu G. Bacteroides salyersiae is a potent chondroitin sulfate-degrading species in the human gut microbiota. Microbiome. 2024;12:41. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The raw metagenomic data on cat gut microbiota of this article can be found online at: https://www.ncbi.nlm.nih.gov/sra/PRJNA1206810.







